Rabeprazolum - Որոնման արդյունքները

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

somac control

takeda gmbh - pantóprazól - meltingarfærakvilla - róteind dæla hemlar - skammtímameðferð á bakflæðissjúkdómum (e. brjóstsviði, sýruuppfall) hjá fullorðnum.

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

pantozol control

takeda gmbh - pantóprazól - meltingarfærakvilla - róteind dæla hemlar - skammtímameðferð á bakflæðissjúkdómum (e. brjóstsviði, sýruuppfall) hjá fullorðnum.

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

vizimpro

pfizer europe ma eeig - dacomitinib einhýdrat - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - vizimpro, eitt og sér, er ætlað fyrir fyrsta lína meðferð fullorðinn sjúklinga með staðnum háþróaður eða sjúklingum ekki lítið klefi lungnakrabbamein (nsclc) með api vöxt þáttur viðtaka (egfr) virkja stökkbreytingar.

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

daurismo

pfizer europe ma eeig - glasdegib maleate - kyrningahvítblæði, mergbólga, bráð - Æxlishemjandi lyf - daurismo is indicated, in combination with low-dose cytarabine, for the treatment of newly diagnosed de novo or secondary acute myeloid leukaemia (aml) in adult patients who are not candidates for standard induction chemotherapy.

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

lumykras

amgen europe bv - sotorasib - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Եվրոպական Միություն - իսլանդերեն - EMA (European Medicines Agency)

sotyktu

bristol-myers squibb pharma eeig - deucravacitinib - psoriasis - Ónæmisbælandi lyf - treatment of moderate-to-severe plaque psoriasis in adults.